논문상세정보
-
- 저자 김수현
- 형태사항 72: 26 cm
- 일반주기 지도교수: 서정향
- 학위논문사항 건국대학교 대학원, 수의학과 수의병리학전공, 학위논문(박사)-, 2021. 8
- 발행지 서울
- 언어 eng
- 출판년 2021
- 발행사항 건국대학교 대학원
- 주제어 Mammary gland tumor Apopto-sis Dogs PIK3CA PTEN TNF-related apoptosis-inducing ligand
TRAIL-Mediated Extrinsic Apoptotic Pathway and PIK3CA Pathway in Canine Mammary Tumors : Analysis in terms of histopathology and molecular pathogenesis = 개의 유선종양에서의 TRAIL 매개성 외인성 세포자멸사 경로와 PIK3CA 경로 : 조직병리학 및 분자생물학 관점에서의 분석
김수현
2021년
'
TRAIL-Mediated Extrinsic Apoptotic Pathway and PIK3CA Pathway in Canine Mammary Tumors : Analysis in terms of histopathology and molecular pathogenesis = 개의 유선종양에서의 TRAIL 매개성 외인성 세포자멸사 경로와 PIK3CA 경로 : 조직병리학 및 분자생물학 관점에서의 분석' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 736 | 0 |
0.0% |
주제별 논문영향력
' TRAIL-Mediated Extrinsic Apoptotic Pathway and PIK3CA Pathway in Canine Mammary Tumors : Analysis in terms of histopathology and molecular pathogenesis = 개의 유선종양에서의 TRAIL 매개성 외인성 세포자멸사 경로와 PIK3CA 경로 : 조직병리학 및 분자생물학 관점에서의 분석' 의 참고문헌
-
Zoppoli, Ceccarelli , M. , Botti , G. , Malanga , D. & Viglietto , G. 2012 . Signaling networks associated with AKT, M. ,Marco , C.Fabiani , F.Franco , R.Pirozzi , G.Rocco , G.Ravo , M.Weisz , A. in non-smalllung cancer ( NSCLC ) : [,]
-
Yang , Q . & Wu , G. 2017 . Cooperative oncogenic effect and cell signaling crosstalk of coDong , L. , MengF. , WuL. , MitchellA.V. , BlockC.J. , ZhangB. , CraigD.B. , Jang ,, Chen , occurring HER2 and mutantin mammary epithelial cells . International journal of [W.]
-
Yamashita, Lu , Y.-S. , Inoue , K. ,? , F.Ciruelos , E.Rubovszky , G.Campone , M.Loibl , S.Rugo , H.S.Iwata , H.Conte , P.Mayer , I.A.Kaufman , B. , M. , P ? pai , Z. , Longin , A.S. , Mills , [,]
-
Y.-H.Functional impact of Galectin-3 and TRAIL expression in breast cancer cellsLiu , X.-H. , DengC.-X. , HuP.-C.Wang , Y .Dong European review for medical and pharmacological sciences21 ( 16 ) , 3626 ? 3633 [2017]
-
V.Prognostic Significance of Canine Mammary Tumor Histologic Subtypes : An Observational Cohort Study of 229 Cases
-
V.Classification and grading of canine mammary tumors . Veterinary pathology
-
Uhlén, M., Fagerberg, L., Hallström, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg, E., Navani, S., Szigyarto, C.A.K., Odeberg, J., Djureinovic, D., Takanen, J.O., Hober, S., Alm, T., Edqvist, P.H., Berling, H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk, J.M., Hamsten, M., von Feilitzen, K., Forsberg, M., Persson, L., Johansson, F., Zwahlen, M., von Heijne, G., Nielsen, J. & Pontén, F. 2015. Proteomics. Tissue-based map of the human proteome. Science. 347(6220), 1260419.Uhl ? nM. , FagerbergL. , Hallstr ? mB.M. ,, C. ,, P. ,,, Sivertsson ,. , KampfC. ,?, E. , AsplundA. , Olsson I., K. , Lundberg , E. , Navani , S. , Szigyarto , C.A.K. , Odeberg , [,]
-
Tumor Cell-selective Synergism of TRAIL- and ATRAinduced Cytotoxicity in Breast Cancer CellsReinhardt , A.Liu , H.Ma , Y.Zhou , Y.Zang , C.Habbel , J.-P.Possinger , K.Eucker , J Anticancer research38 ( 5 ) , 2669 ? 2682 [2018]
-
The PI3K Pathway in Human DiseaseFruman , D.A.Chiu , H.Hopkins , B.D.Bagrodia , S.Cantley , L.C .Abraham , R.T. Cell170 ( 4 ) , 605 ? 635 [2017]
-
TRAIL of Hope Meeting Resistance in Cancer
-
T. , Sheppard , K.E. , Ryland , G.L. , Campbell , I.G. , Gorringe ,, K.M. , Montgomery ,, Kleinschmidt ,, Waring ,, Ivetac ,, Tikoo ,,, M. ,, L.Roh , V. , Christensen , J.G. ,, C. , Hicks , R.J. , Pearson [Mantamadiotis]
-
Symmans , W.F. , Pusztai , L. , Nolden , L.K. , Horlings , H. , Berns, K. ,, A.M. , Lluch ,, Neve ,,, W.-L. ,, M. ,, M. ,, Z. , GuanY. , Sahin K. ,, M.C. , van de Vijver , M.J. [A.]
-
Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL )Elders , R.C.Baines , S.J .Catchpole , B . Veterinary immunology and immunopathology . 130 ( 1 ? 2 ) , 11 ? 16 [2009]
-
Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicinSpee , B.Jonkers , M.D.B.Arends , B.Rutteman , G.R.Rothuizen , J .Penning , L.C Molecular cancer5 , 34 [2006]
-
Somatic Mutation of PIK3CA ( H1047R ) Is a Common Driver Mutation Hotspot in Canine Mammary Tumors as Well as Human Breast Cancers
-
Sedger, L.M., Glaccum, M.B., Schuh, J.C.L., Kanaly, S.T., Williamson, E., Kayagaki, N., Yun, T., Smolak, P., Le, T., Goodwin, R. & Gliniak, B. 2002.
-
S. Canine tumor mutation rate is positively correlated with TP53 mutation across cancer types and breedsAlsaihati , B.A.Ho , K.L.Watson , J.Feng , Y.WangT. & Zhao 07 . 15. https : //www.biorxiv.org/content/10.1101/2020.07.15.205286v1 ( 2021.04.21 [2020]
-
S. 2019 . Expression profiles of TRAIL and its receptors in normal , hyperplastic , and malignant endometrial tissues : Hints on endometrial cancer biologyAydin , C.Bisgin , A.Sanlioglu , A.D.Pestereli , E.Erdogan , G.Ozbudak , I.H.SimsekT. & Sanlioglu Eastern Journal Of Medicine24 ( 3 ) , 361 ? 370
-
S. 2003 . Expression of TRAIL ( TNF-related apoptosis-inducing ligand ) and its receptors in normal colonic mucosa , adenomas , and carcinomasKoornstra , J.J.Kleibeuker , J.H.van GeelenC.M.M. , RijckenF.E.M. , HollemaH.de VriesE.G.E .de Jong The Journal of pathology200 ( 3 ) , 327 ? 335
-
Repression of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL ) but not its receptors during oral cancer progression
-
Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumorsRessel , L. , MillantaF. , CaleriE. , InnocentiV.M .Poli , A . Veterinary pathology46 ( 5 ) , 860 ? 868 [2009]
-
R.A.Hallmarks of Cancer : The Next Generation
-
Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors : Comparison with immunohistochemistry analysis
-
Prognostic significance of TMEM16A , PPFIA1 , and FADD expression in invasive ductal carcinoma of the breastChoi , E.J.Yun , J.A.Jabeen , S.Jeon , E.K.Won , H.S.Ko , Y.H .Kim , S.Y World journal of surgical oncology12 , 137 [2014]
-
Procaspase-3 Overexpression in Cancer : A Paradoxical Observation with Therapeutic Potential
-
Phosphatase and Tensin Homologue : Novel Regulation by Developmental Signaling
-
PTEN , PIK3CA , p-AKT , and pp70S6K status : association with trastuzumab response and survival, F.J. ,, H. ,, S. ,, C. ,,, Lanchbury ,, SahinA.A. , Hortobagyi.Yu , D. patients with HER2-positive metastatic breast. The American journal of pathology . 177 [,]
-
PIK3CA mutations matter for cancer in dogs
-
PIK3CA mutations in glioblastoma multiformeHartmann , C.Bartels , G.Gehlhaar , C.Holtkamp , N.von DeimlingA . Acta neuropathologica109 ( 6 ) , 639 ? 642 [2005]
-
PIK3CA mutation associates with improved outcome in breast cancerKalinsky , K.Jacks , L.M.Heguy , A.Patil , S.Drobnjak , M.Bhanot , U.K.Hedvat , C.V.Traina , T.A.Solit , D.Gerald , W.Moynahan , M.E Clinical cancer research15 ( 16 ) , 5049 ? 5059 [2009]
-
PIK3CA in cancer : The past 30 years . Seminars in cancer biology
-
PI3K/PTEN/AKT pathway . A critical mediator of oncogenic signaling . Cancer treatment and research
-
PI3K-independent AKT activation in cancers : a treasure trove for novel therapeutics
-
P.The multifaceted role of TRAIL signaling in cancer and immunity
-
Mutation of the PIK3CA gene in ovarian and breast cancerCampbell , I.G. , Russell , S.E.Choong , D.Y.H.Montgomery , K.G.Ciavarella , M.L.Hooi , C.S.F.Cristiano , B.E.PearsonR.B .Phillips , W.A Cancer research64 ( 21 ) , 7678 ? 7681 [2004]
-
Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokineGriffith , T.S. , WileyS.R. , KubinM.Z. , SedgerL.M. , MaliszewskiC.R .Fanger , N.A TRAIL . The Journal of experimental medicine189 ( 8 ) , 1343 ? 1354 [1999]
-
M.Tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL ) activates caspases in human prostate cancer cells through sigma 1 receptor . Biochemical and biophysical research communicationsDas , D.Persaud , L.Dejoie , J.Happy , M.Brannigan , O.De JesusD. & Sauane 470 ( 2 ) , 319 ? 323 [2016]
-
M.Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumorsMeyer , D.S.Brinkhaus , H.M ? llerU. , M ? llerM. , CardiffR.D .Bentires-Alj Cancer research71 ( 13 ) , 4344 ? 4351 [2011]
-
M.J.Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient miceCretney , E.Takeda , K.Yagita , H.GlaccumM. , PeschonJ.J. & Smyth Journal of immunologyBaltimore , Md . : 1950168 ( 3 ) , 1356 ? 1361 [2002]
-
M.Distinct functions of AKT isoforms in breast cancer : a comprehensive review
-
M. 2015 . PIK3CA ( H1047R ) induces multipotency and, S. ,, L. ,, J.P. , De, D. ,, M.B. ,, T. ,, A. ,, T. ,, H. ,,, CardiffR.D . & mammary. Nature . 525 ( 7567 ) , [Bentires-Alj]
-
L.TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor . Biochimica et biophysica actaNahacka , Z.Svadlenka , J.Peterka , M.Ksandrova , M.Benesova , S.Neuzil , J . Molecular cell research . 1865 ( 3 ) , 522 ? 531 [Andera2018]
-
L.PTEN : Multiple Functions in Human Malignant Tumors
-
L. 2008 . Expression and significance of PTEN in canine mammary gland tumours . Research in veterinary science
-
Kawauchi. & Miki , T. 2013 . Significance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal, D. ,, N. ,, M. ,, T. ,, Y. ,, T. ,, F. ,, K. , Kamoi carcinoma . Molecular and clinical oncology . 1 [K.,]
-
K. 2000 . Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors . Histochemistry and cell biology
-
Identification and characterization of a new member of the TNF family that induces apoptosisS.R. , Schooley , K.Smolak , P.J.Din , W.S.Huang , C.P.Nicholl , J.K.Sutherland , G.R.Smith , T.D.Rauch , C.Smith , C.A Immunity . 3 ( 6 ) , 673 ? 682 [1995]
-
H.Trimer form of tumor necrosis factor-related apoptosis inducing ligand induces apoptosis in canine cell lines derived from mammary tumorsGoto , M.Hirata , A.Murakami , M. The Journal of veterinary medical science81 ( 12 ) , 1791 ? 1803 [2019]
-
H., S. , Nakai , C. , Matsushima , K. , Suzuki , Y. , Akagi, S. , Yoshino ,, Yamazaki ,, Muro ,, Yamaguchi ,, Nishina ,, Yuki ,, Shinozaki ,, Shitara , K. K. ,, T. , Nomura , S. , Esumi [Bando,]
-
G.Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer
-
G.G. , Williamson , E.J. , English , D.R . & Buchanan ,, C. , Young ,, Walsh ,, Clendenning ,, Sanderson ,, Walters ,, Parry ,, Jenkins ,, Win ,,, M.C.Hopper , J.L. . 2013PIK3CA activating mutation in colorectal carcinoma [Giles]
-
G.Clinical Significance of PIK3CA Gene in Non-Small-Cell Lung Cancer : A Systematic Review and Meta- Analysis
-
From procaspase-8 to caspase-8 : revisiting structural functions of caspase-8
-
FADD induces NF-kappaB , perturbs cell cycle , and is associated with poor outcome in lung adenocarcinomasProceedings of the National Academy of Sciences of the United States of America102 ( 35 ) , 12507 ? 12512
-
E.PI3K/AKT signaling pathway and cancer : an updated reviewMartini , M.De SantisM.C. , BracciniL. , GulluniF. & Hirsch Annals of medicine46 ( 6 ) , 372 ? 383 [2014]
-
Downregulation of TNF-related apoptosis-inducing ligand ( TRAIL ) /Apo2L in Barrett ’ s esophagus with dysplasia and adenocarcinoma . Applied immunohistochemistry & molecular morphologyPopnikolov , N.K. , GatalicaZ. , AdegboyegaP.A. , NorrisB.A .Pasricha , P.J 14 ( 2 ) , 161 ? 165 [2006]
-
Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies ?
-
Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formationAdams , J.R.Xu , K.Liu , J.C.Agamez , N.M.R.Loch , A.J.Wong , R.G.Wang , W.Wright , K.L.Lane , T.F.Zacksenhaus , E.Egan , S.E Cancer research71 ( 7 ) , 2706 ? 2717 [2011]
-
Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancerArsenic , R.Treue , D.Lehmann , A.Hummel , M.Dietel , M.Denkert , C.Budczies , J BMC clinical pathology15 , 20 [2015]
-
Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenograftsDuan , W.R.Garner , D.S.Williams , S.D.Funckes-Shippy , C.L.SpathI.S .Blomme , E.A.G The Journal of pathology199 ( 2 ) , 221 ? 228 [2003]
-
Cloning and apoptosis-inducing activities of canine and feline TRAIL
-
Clinicopathological Significance of Elevated PIK3CA Expression in Gastric CancerJang , S.-H.Kim , K.-J.Oh , M.-H.Lee , J.-H.Lee , H.J.Cho , H.D.HanS.W. , SonM.W .Lee , M.S Journal of gastric cancer16 ( 2 ) , 85 ? 92 [2016]
-
Classes of phosphoinositide 3-kinases at a glance
-
Chen, G., Bhojani, M.S., Heaford, A.C., Chang, D.C., Laxman, B., Thomas, D.G., Griffin, L.B., Yu, J., Coppola, J.M., Giordano, T.J., Lin, L., Adams, D., Orringer, M.B., Ross, B.D., Beer, D.G. & Rehemtulla, A. 2005.
-
Characterization of the in vivo function of TNF-alpha-related apoptosisinducing ligand , TRAIL/Apo2L , using TRAIL/Apo2L gene-deficient miceEuropean journal of immunology . 32 ( 8 ) , 2246 ? 2254
-
Ch ’ En , P.Expression of TRAIL and TRAIL receptors in normal and malignant tissuesDaniels , R.A.Turley , H.Kimberley , F.C.Liu , X.S.Mongkolsapaya , J.XuX.N.JinB.Q. , PezzellaF. & ScreatonG.R . Cell research15 ( 6 ) , 430 ? 438 [2005]
-
Caspase-8 : fly or die . Cancer research . 68 ( 12PI3K and cancer : lessons , challenges and opportunities
-
C.Analysis of PIK3CA mutations in breast cancer subtypesArsenic , R.Lehmann , A.Budczies , J.Koch , I.Prinzler , J.Kleine-Tebbe , A.Schewe , C.Loibl , S.Dietel , M.Denkert Applied immunohistochemistry & molecular morphology : AIMM . 22 ( 1 ) , 50 ? 56 [2014]
-
C.-T.Proliferative activity , apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumoursYang , W.-Y.Liu , C.-H.Chang , C.-J.Lee , C.-C.Chang , K.-J .Lin Journal of comparative pathology134 ( 1 ) , 70 ? 79 [2006]
-
Apoptotic cell death under hypoxia
-
Apoptosis as a prognostic marker in canine mammary tumors by TUNELPereira , K.S. , ZuccariD.A.P . de C.Cury , P.M.Cordeiro , J.A Brazilian Journal of Veterinary Research and Animal Science40 , 359 ? 365 [2003]
-
Apoptosis : a review of programmed cell death
-
Apoptosis : a link between cancer genetics and chemotherapy
-
Analysis of Hypoxia- Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary TumoursShin , J.I.Lim , H.Y.Kim , H.W.Seung , B.J .Sur , J.H Journal of comparative pathology153 ( 2 ? 3 ) , 101 ? 110 [2015]
-
An immunohistochemical study on the expression of sex steroid receptors in canine mammary tumors
-
An Immunohistochemical Study of the PTEN/AKT Pathway Involvement in Canine and Feline Mammary Tumors
-
Activation of STAT3 , MAPK , and AKT in malignant astrocytic gliomas : correlation with EGFR status , tumor grade , and survivalMizoguchi , M.Betensky , R.A.Batchelor , T.T.Bernay , D.C.Louis , D.N .Nutt , C.L Journal of neuropathology and experimental neurology65 ( 12 ) , 1181 ? 1188 [2006]
-
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteinsRiggio , M. , PerroneM.C. , PoloM.L. , RodriguezM.J.May , M.Abba , M.Lanari , C.NovaroV. Scientific reports7 , 44244 [2017]
-
A.D.Measures of cell turnover ( proliferation and apoptosis ) and their association with survival in breast cancer
-
2007 . PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive inP ? rez-TenorioG. , AlkhoriL. , OlssonB. , WalterssonNordenskjld , B.RutqvistL.E. , SkoogStl , cancer . Clinicalresearch . 13 ( 12 ) , 3577 [O]
-
,Sfanos , K.S . & De Marzo , A.M. 2017 . Rapid Loss of RNA Detection by In Situ Hybridization inBaena-Del Valle , J.A. ,, Q. ,, J.L. ,, H. ,,, Morrissey ,, CoreyE. , Tissue Blocks and Preservation byStorage of Unstained Slides . American journal of [T.C.]
-
,Kim , S. 2020 . Crossspecies oncogenic signatures of breast, T.-M. , Yang ,, Seung ,, Lee ,, Kim ,, Ha ,,, M.-K.Kim , K.-, Kim ,, Cheong , J.-H. ,,, in canine mammarytumors . Nature communications . 11 [H.]
-
, Won , H.H. , Li , Y. , Cantley , L.C. , Winer , E. & Arteaga , C.L ., I.A. ,, V.G. ,, L. ,, J.M. ,, M.V. ,, M.E. ,, D. ,, D. , . A PhaseStudy of Alpelisib ( BYL719 ) , a [,]
-
, T.M. , Lum , B.L. , Ashkenazi , A. , Jubb , A.M. & Mendelson , D.S . 2010, R.S. ,, S.G. ,, R. ,, S. ,’ Dwyer ,, Gordon ,, Novotny ,, Goldwasser , Phase I dose-escalation studyrecombinant human Apo2L/TRAIL , a dual proapoptotic receptor [,]
-
, Rodr ? guez , A. , Mart ? nez
-
, Nagatsuma , A.K . & Ochiai , A . 2018 . In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number byKuboki , Y.Schatz , C.A.Koechert , K.Schubert , S.Feng , J.Wittemer-RumpS. ,, K. , in situin a large cohort of gastric cancer patients [,]
-
, K.W. , Vogelstein , B . & Velculescu , V.ESamuels , Y. , WangZ. , BardelliA. , SillimanN. , PtakJ. , SzaboS. , YanH. , GazdarA. , PowellS.M. , RigginsG.J. , Willson ,, Markowitz , 2004 .High frequency of mutations of the [,]
-
, Coy , J.F. , El-Bahrawy , M.A. , Bergmann , F. ,, R.von Karstedt ,, Conti ,, Nobis ,, Montinaro ,, Hartwig ,, Lemke ,, Legler ,,, F. ,, A.D. , TaraborrelliL. , Grosse-Wilde Werner , J. , Ganten , T.M. , [,]
-
, Carr , J.M. , Crook , J.E. , Moreno-Aspitia , A. , Anastasiadis , P.Z. , Perez , E.A . & Thompson , E.A . 2016 .Norton , N. , AdvaniP.P. , SerieD.J. , GeigerX.J. , NecelaB.M. , AxenfeldB.C. ,, J.M. , of Tumor, as Evidenced by Gene Expression [,]
-
, Beijersbergen , R.L. , Mills , G.B. , van de Vijver , M.J. & Bernards , R.Berns , K.Horlings , H.M.Hennessy , B.T.Madiredjo , M.Hijmans , E.M.Beelen , K.Linn , S.C.Gonzalez-Angulo , A.M.Stemke-Hale , K.Hauptmann . Agenetic approach identifies the PI3K pathway as a [,]
-
&F. 2018 . PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene . Advances in clinical